Skip to main content
. 2014 Mar 25;9(3):e93310. doi: 10.1371/journal.pone.0093310

Figure 2. UCP-1 and β-actin protein expression in each treatment group (vehicle, olanzapine, olanzapine + berberine, olanzapine + metformin) (A).

Figure 2

Quantification of relative protein expression of UCP-1 to β-actin, when normalized with the control group (B). * denotes significant difference at P<0.05.